🇺🇸 Dapagliflozin 10mg in United States

12 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Asthenia — 2 reports (16.67%)
  2. Ketoacidosis — 2 reports (16.67%)
  3. Abdominal Pain — 1 report (8.33%)
  4. Anticoagulation Drug Level Below Therapeutic — 1 report (8.33%)
  5. Blood Glucose Increased — 1 report (8.33%)
  6. Diabetic Ketoacidosis — 1 report (8.33%)
  7. Dyspnoea — 1 report (8.33%)
  8. Fatigue — 1 report (8.33%)
  9. Ketonuria — 1 report (8.33%)
  10. Lethargy — 1 report (8.33%)

Source database →

Dapagliflozin 10mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dapagliflozin 10mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dapagliflozin 10mg in United States?

LG Chem is the originator. The local marketing authorisation holder may differ — check the official source linked above.